Susquehanna International Group’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,100
Closed -$29.5K 12686
2023
Q4
$29.5K Sell
18,100
-43,700
-71% -$74.9K ﹤0.01% 11884
2023
Q3
$184K Sell
61,800
-55,400
-47% -$211K ﹤0.01% 10319
2023
Q2
$523K Buy
+117,200
New +$525K ﹤0.01% 8206
2022
Q1
Sell
-254,200
Closed -$1.21M 13445
2021
Q4
$1.21M Buy
254,200
+155,600
+158% +$626K ﹤0.01% 6779
2021
Q3
$255K Buy
98,600
+87,900
+821% +$232K ﹤0.01% 10969
2021
Q2
$32K Buy
+10,700
New +$35.5K ﹤0.01% 12379
2021
Q1
Sell
-47,600
Closed -$239K 12498
2020
Q4
$239K Sell
47,600
-12,000
-20% -$54K ﹤0.01% 9740
2020
Q3
$254K Buy
+59,600
New +$274K ﹤0.01% 9034

Other funds holding IFRX

Susquehanna International Group's IFRX Position: Q1 2026 in Review

Susquehanna International Group increased its InflaRx (IFRX) stake by 96% in Q1 2026, buying an estimated $35.7K and bringing the position to 77,114 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #12520.

Susquehanna International Group first reported a position in IFRX in Q2 2020 and has held it in 19 quarters since. The position peaked at $795K in Q2 2023. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • Susquehanna International Group held 77,114 shares of InflaRx worth $69K as of Q1 2026.
  • Susquehanna International Group bought 37,741 InflaRx shares in Q1 2026, an estimated $35.7K.
  • InflaRx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12520 holding.
  • Susquehanna International Group first reported a position in InflaRx in Q2 2020 and has held it in 19 quarters since.
  • Susquehanna International Group's InflaRx position peaked at $795K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.